ATE307111T1 - Serinprotease-inhibitoren - Google Patents
Serinprotease-inhibitorenInfo
- Publication number
- ATE307111T1 ATE307111T1 AT00911572T AT00911572T ATE307111T1 AT E307111 T1 ATE307111 T1 AT E307111T1 AT 00911572 T AT00911572 T AT 00911572T AT 00911572 T AT00911572 T AT 00911572T AT E307111 T1 ATE307111 T1 AT E307111T1
- Authority
- AT
- Austria
- Prior art keywords
- serine protease
- protease inhibitors
- compounds
- factor
- kallikrein
- Prior art date
Links
- 239000003001 serine protease inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010053567 Coagulopathies Diseases 0.000 abstract 1
- 108010054265 Factor VIIa Proteins 0.000 abstract 1
- 108010074860 Factor Xa Proteins 0.000 abstract 1
- 108060005987 Kallikrein Proteins 0.000 abstract 1
- 102000001399 Kallikrein Human genes 0.000 abstract 1
- 108010022999 Serine Proteases Proteins 0.000 abstract 1
- 102000012479 Serine Proteases Human genes 0.000 abstract 1
- 108090000190 Thrombin Proteins 0.000 abstract 1
- 229940012414 factor viia Drugs 0.000 abstract 1
- 229960004072 thrombin Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/03—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C311/05—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atoms of the sulfonamide groups bound to hydrogen atoms or to acyclic carbon atoms to acyclic carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C257/00—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines
- C07C257/10—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines
- C07C257/18—Compounds containing carboxyl groups, the doubly-bound oxygen atom of a carboxyl group being replaced by a doubly-bound nitrogen atom, this nitrogen atom not being further bound to an oxygen atom, e.g. imino-ethers, amidines with replacement of the other oxygen atom of the carboxyl group by nitrogen atoms, e.g. amidines having carbon atoms of amidino groups bound to carbon atoms of six-membered aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/12—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings
- C07C311/13—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing rings the carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
- C07C311/18—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms, not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/50—Compounds containing any of the groups, X being a hetero atom, Y being any atom
- C07C311/51—Y being a hydrogen or a carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11577299P | 1999-01-13 | 1999-01-13 | |
| US15202999P | 1999-09-01 | 1999-09-01 | |
| PCT/US2000/000673 WO2000041531A2 (en) | 1999-01-13 | 2000-01-11 | Serine protease inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE307111T1 true ATE307111T1 (de) | 2005-11-15 |
Family
ID=26813550
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00911572T ATE307111T1 (de) | 1999-01-13 | 2000-01-11 | Serinprotease-inhibitoren |
Country Status (19)
| Country | Link |
|---|---|
| US (4) | US6472393B1 (de) |
| EP (1) | EP1144373B1 (de) |
| JP (1) | JP2002534449A (de) |
| KR (1) | KR100838418B1 (de) |
| CN (1) | CN100488947C (de) |
| AT (1) | ATE307111T1 (de) |
| AU (1) | AU771776B2 (de) |
| BR (1) | BR0008755A (de) |
| CA (1) | CA2356934A1 (de) |
| CZ (1) | CZ20012508A3 (de) |
| DE (1) | DE60023266T2 (de) |
| ES (1) | ES2251363T3 (de) |
| HU (1) | HUP0105077A3 (de) |
| IL (2) | IL144032A0 (de) |
| MX (1) | MXPA01007038A (de) |
| NO (1) | NO20013462L (de) |
| NZ (1) | NZ512736A (de) |
| PL (1) | PL350042A1 (de) |
| WO (1) | WO2000041531A2 (de) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL144032A0 (en) * | 1999-01-13 | 2002-04-21 | Genentech Inc | Serine protease inhibitors |
| AU7447500A (en) * | 1999-09-30 | 2001-04-30 | Mitsubishi Chemical Corporation | Acylsulfonamide derivatives |
| CA2426430C (en) | 2000-10-20 | 2014-10-07 | Biocryst Pharmaceuticals, Inc. | Biaryl compounds as serine protease inhibitors |
| JP4179878B2 (ja) | 2001-02-02 | 2008-11-12 | 中外製薬株式会社 | ペプチド誘導体 |
| DE10130374A1 (de) * | 2001-06-23 | 2003-01-02 | Boehringer Ingelheim Pharma | Substituierte N-Acyl-anilinderivate, deren Herstellung und deren Verwendung als Arzneimittel |
| AU2003219039A1 (en) * | 2002-03-11 | 2003-09-22 | Curacyte Ag | Urokinase inhibitors, production and use thereof |
| GB0207637D0 (en) * | 2002-04-02 | 2002-05-15 | Karobio Ab | Novel compound |
| AU2003231865A1 (en) * | 2002-05-31 | 2003-12-19 | Genzyme Corporation | Alpha acyloxyacetamides for kallikrein and urokinase inhibition |
| DE10301300B4 (de) * | 2003-01-15 | 2009-07-16 | Curacyte Chemistry Gmbh | Verwendung von acylierten 4-Amidino- und 4-Guanidinobenzylaminen zur Inhibierung von Plasmakallikrein |
| US7122559B2 (en) * | 2003-02-11 | 2006-10-17 | Bristol-Myers Squibb Company | Phenylglycine derivatives useful as serine protease inhibitors |
| US7144895B2 (en) * | 2003-02-11 | 2006-12-05 | Bristol-Myers Squibb Co. | Benzene acetamide compounds useful as serine protease inhibitors |
| AU2004249670A1 (en) | 2003-05-20 | 2004-12-29 | Genentech, Inc. | Acylsulfamide inhibitors of factor VIIa |
| JP2007500221A (ja) * | 2003-05-20 | 2007-01-11 | ジェネンテック・インコーポレーテッド | 第ＶＩＩａ因子のベンゾフラン阻害剤 |
| DE10342108A1 (de) * | 2003-09-11 | 2005-04-14 | Curacyte Chemistry Gmbh | Basisch-substituierte Benzylaminanaloga als Inhibitoren des Gerinnungsfaktors Xa, ihre Herstellung und Verwendung |
| AR054321A1 (es) * | 2005-01-10 | 2007-06-20 | Bristol Myers Squibb Co | Derivados en fenilglicinamida utiles como anticoagulantes |
| CA2602533A1 (en) | 2005-03-29 | 2006-10-05 | Biocryst Pharmaceuticals, Inc. | Use of c-nucleoside analogs for treatment of hepatitis c related viral infections |
| US7964619B2 (en) | 2005-06-03 | 2011-06-21 | The University Of North Carolina At Chapel Hill | Teraryl components as antiparasitic agents |
| AU2006202083A1 (en) * | 2005-06-03 | 2006-12-21 | Reto Brun | Linear dicationic terphenyls and their aza analogues as antiparasitic agents |
| DE602006011752D1 (de) * | 2005-06-24 | 2010-03-04 | Bristol Myers Squibb Co | Als antikoagulationsmittel geeignete phenylglycinamid- und pyridylglycinamidderivate |
| EP2000465B1 (de) | 2006-03-24 | 2010-12-15 | Eisai R&D Management Co., Ltd. | Triazolonderivat |
| US7776832B2 (en) | 2006-04-21 | 2010-08-17 | Gem Pharmaceuticals, Llc | Anticancer treatment with a combination of taxanes and 13-deoxyanthracyclines |
| DE102006050672A1 (de) | 2006-10-24 | 2008-04-30 | Curacyte Discovery Gmbh | Hemmstoffe des Plasmins und des Plasmakallikreins |
| TW200831080A (en) * | 2006-12-15 | 2008-08-01 | Irm Llc | Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| NZ598927A (en) | 2007-01-12 | 2013-09-27 | Biocryst Pharm Inc | Antiviral nucleoside analogs |
| EP2161023A3 (de) | 2007-04-13 | 2010-12-29 | Southern Research Institute | Anti-Angiogenese-Mittel und Anwendungsverfahren dafür |
| WO2009018405A1 (en) * | 2007-07-31 | 2009-02-05 | Mallinckrodt Inc. | Integrated photoactive agents and uses thereof |
| JPWO2009038157A1 (ja) | 2007-09-21 | 2011-01-06 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | ２，３−ジヒドロ−イミノイソインドール誘導体 |
| TW200942243A (en) | 2008-03-05 | 2009-10-16 | Biocryst Pharm Inc | Antiviral therapeutic agents |
| WO2010036407A2 (en) | 2008-05-15 | 2010-04-01 | Biocryst Pharmaceuticals, Inc. | Antiviral nucleoside analogs |
| CN102448473A (zh) | 2009-03-10 | 2012-05-09 | Med发现公司 | 丝氨酸蛋白酶抑制剂在治疗嗜中性粒细胞减少症中的用途 |
| TW201206905A (en) | 2010-05-20 | 2012-02-16 | Eisai R & Amp D Man Co Ltd | Prodrug of triazolone compound |
| ES2483802T3 (es) | 2010-07-07 | 2014-08-07 | The Medicines Company (Leipzig) Gmbh | Inhibidores de serina proteasa |
| WO2013166276A1 (en) | 2012-05-02 | 2013-11-07 | Southern Research Institute | Triazolopyridazine compounds, use as inhibitors of the kinase lrrk2, and methods for preparation thereof |
| ES2919024T3 (es) | 2014-02-11 | 2022-07-21 | Mitokinin Inc | Composiciones y procedimientos que utilizan las mismas para el tratamiento de enfermedades neurodegenerativas y mitocondriales |
| CN108934162A (zh) | 2015-12-16 | 2018-12-04 | 南方研究所 | 吡咯并嘧啶化合物、作为激酶lrrk2抑制剂的用途及其制备方法 |
| CN110177553A (zh) | 2016-11-17 | 2019-08-27 | 北卡罗来纳大学教堂山分校 | 烷基吡咯并嘧啶类似物及其制备和使用方法 |
| US10450263B2 (en) | 2017-02-10 | 2019-10-22 | Southern Research Institute | Benzo annulenes as antiviral agents |
| US11160826B1 (en) | 2017-03-03 | 2021-11-02 | United States Government As Represented By The Department Of Veterans Affairs | Cholesterol lowering drugs for the treatment of hepatic encephalopathy |
| WO2018237145A1 (en) | 2017-06-21 | 2018-12-27 | Mitokinin, Inc. | Compositions and methods using the same for treatment of neurodegenerative and mitochondrial disease |
| US11046729B2 (en) | 2017-10-26 | 2021-06-29 | Southern Research Institute | Dipeptide analogs as TGF-beta inhibitors |
| EP3551188B1 (de) | 2017-10-31 | 2023-10-18 | Southern Research Institute | Substituierte chinazolinsulfonamide als inhibitoren des thioredoxin-interagierenden proteins (txnip) |
| TWI873092B (zh) | 2018-04-06 | 2025-02-21 | 美商百歐克斯製藥公司 | 取代的苯并呋喃、苯并吡咯、苯并噻吩及結構相關的補體抑制劑 |
| US20210363170A1 (en) | 2018-04-19 | 2021-11-25 | Southern Research Institute | 4'-thio-nucleotide and -nucleoside prodrugs for the treatment of cancer |
| ES3063585T3 (en) | 2018-10-02 | 2026-04-17 | Us Gov Veterans Affairs | Spak kinase inhibitors as neuroprotective agents |
| CN113993521A (zh) | 2019-06-05 | 2022-01-28 | 南方研究院 | 基于噻拉滨和噻拉滨前药的治疗 |
| KR20220034780A (ko) | 2019-06-14 | 2022-03-18 | 써던 리서취 인스티튜트 | 2,4,7-치환된-7-데아자-2'-데옥시-2'-플루오로아라비노실 뉴클레오사이드 및 뉴클레오타이드 전구약물 및 이의 용도 |
| WO2021055518A1 (en) | 2019-09-17 | 2021-03-25 | University Of Utah Research Foundation | Benzimidazoles and methods of using same |
| TWI908740B (zh) | 2019-10-09 | 2025-12-21 | 美商百歐克斯製藥公司 | 口服補體因子d抑制劑 |
| EP4069270A4 (de) | 2019-12-04 | 2024-01-03 | Southern Research Institute | Modulatoren von programmiertem tod-ligand-1 und/oder programmiertem tod-ligand-2 |
| US11566019B2 (en) | 2020-04-02 | 2023-01-31 | Southern Research Institute | 2-pyrimidone analogs as potent antiviral agents against alphaviruses |
| AR121715A1 (es) | 2020-04-03 | 2022-06-29 | Biocryst Pharm Inc | Pirrolopirimidinaminas como inhibidores del sistema del complemento |
| WO2021222637A1 (en) | 2020-04-30 | 2021-11-04 | United States Government As Represented By The Department Of Veterans Affairs | Krüppel-like factor 15 (klf15) small molecule agonists in kidney disease |
| CA3194653A1 (en) | 2020-10-02 | 2022-04-07 | Mitokinin, Inc. | Compositions and methods of treating kidney disease and fibrosis |
| WO2022109066A1 (en) | 2020-11-18 | 2022-05-27 | Southern Research Institute | Compounds for the treatment of acute and chronic kidney disease |
| EP4247375A4 (de) | 2020-11-18 | 2024-11-20 | Southern Research Institute | Verbindungen zur behandlung von akuter und chronischer nierenerkrankung |
| EP4422643A4 (de) | 2021-10-26 | 2025-11-26 | Southern Res Inst | Entwicklung neuartiger clofarabin-analoga zur krebstherapie |
| US11905306B2 (en) | 2021-12-21 | 2024-02-20 | Southern Research Institute | Substituted phenyl ethynyl pyridine carboxamides as potent inhibitors of SARS virus |
| US20250108066A1 (en) | 2022-01-27 | 2025-04-03 | Trilink Biotechnologies, Llc | Trinucleotide cap analogs and methods of use thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ZA928276B (en) | 1991-10-31 | 1993-05-06 | Daiichi Seiyaku Co | Aromatic amidine derivates and salts thereof. |
| DE4342154A1 (de) | 1993-12-10 | 1995-06-14 | Behringwerke Ag | Amidinophenylalaninderivate, Verfahren zu deren Herstellung, deren Verwendung und diese enthaltende Mittel als Antikoagulantien |
| NZ296210A (en) | 1994-12-02 | 1998-05-27 | Yamanouchi Pharma Co Ltd | Amidinonaphthyl derivatives to inhibit activated blood coagulation factor x |
| EP0813525B9 (de) * | 1995-03-10 | 2004-02-04 | Berlex Laboratories, Inc. | Benzamidin-derivate, deren herstellung und deren verwendung als anti-koagulantien |
| JP2000514788A (ja) * | 1996-06-25 | 2000-11-07 | イーライ・リリー・アンド・カンパニー | 抗凝固剤 |
| US6020357A (en) * | 1996-12-23 | 2000-02-01 | Dupont Pharmaceuticals Company | Nitrogen containing heteroaromatics as factor Xa inhibitors |
| TW542822B (en) * | 1997-01-17 | 2003-07-21 | Ajinomoto Kk | Benzamidine derivatives |
| AU747531B2 (en) * | 1997-04-14 | 2002-05-16 | Millennium Pharmaceuticals, Inc. | Selective factor Xa inhibitors |
| EP0977772A1 (de) * | 1997-04-14 | 2000-02-09 | Cor Therapeutics, Inc. | Selektive faktor xa-inhibitoren |
| US6369063B1 (en) * | 1997-04-14 | 2002-04-09 | Cor Therapeutics, Inc. | Selective factor Xa inhibitors |
| US6133256A (en) * | 1997-04-14 | 2000-10-17 | Cor Therapeutics Inc | Selective factor Xa inhibitors |
| DE19718181A1 (de) | 1997-04-30 | 1998-11-05 | Boehringer Ingelheim Pharma | Disubstituierte bicyclische Heterocyclen, ihre Herstellung und ihre Verwendung als Arzneimittel |
| US5998424A (en) * | 1997-06-19 | 1999-12-07 | Dupont Pharmaceuticals Company | Inhibitors of factor Xa with a neutral P1 specificity group |
| EP0987274A1 (de) * | 1998-09-15 | 2000-03-22 | Hoechst Marion Roussel Deutschland GmbH | Faktor VIIa Inhibitore |
| IL144032A0 (en) * | 1999-01-13 | 2002-04-21 | Genentech Inc | Serine protease inhibitors |
-
2000
- 2000-01-11 IL IL14403200A patent/IL144032A0/xx active IP Right Grant
- 2000-01-11 DE DE60023266T patent/DE60023266T2/de not_active Expired - Lifetime
- 2000-01-11 JP JP2000593153A patent/JP2002534449A/ja active Pending
- 2000-01-11 NZ NZ512736A patent/NZ512736A/en not_active IP Right Cessation
- 2000-01-11 BR BRPI0008755-6A patent/BR0008755A/pt not_active Application Discontinuation
- 2000-01-11 AT AT00911572T patent/ATE307111T1/de not_active IP Right Cessation
- 2000-01-11 ES ES00911572T patent/ES2251363T3/es not_active Expired - Lifetime
- 2000-01-11 US US09/509,104 patent/US6472393B1/en not_active Expired - Fee Related
- 2000-01-11 HU HU0105077A patent/HUP0105077A3/hu not_active Application Discontinuation
- 2000-01-11 CN CNB008044228A patent/CN100488947C/zh not_active Expired - Fee Related
- 2000-01-11 CZ CZ20012508A patent/CZ20012508A3/cs unknown
- 2000-01-11 CA CA002356934A patent/CA2356934A1/en not_active Abandoned
- 2000-01-11 KR KR1020017008804A patent/KR100838418B1/ko not_active Expired - Fee Related
- 2000-01-11 MX MXPA01007038A patent/MXPA01007038A/es active IP Right Grant
- 2000-01-11 AU AU33451/00A patent/AU771776B2/en not_active Ceased
- 2000-01-11 EP EP00911572A patent/EP1144373B1/de not_active Expired - Lifetime
- 2000-01-11 PL PL00350042A patent/PL350042A1/xx not_active Application Discontinuation
- 2000-01-11 WO PCT/US2000/000673 patent/WO2000041531A2/en not_active Ceased
-
2001
- 2001-06-27 IL IL144032A patent/IL144032A/en not_active IP Right Cessation
- 2001-07-12 NO NO20013462A patent/NO20013462L/no not_active Application Discontinuation
-
2002
- 2002-08-19 US US10/224,114 patent/US6919369B2/en not_active Expired - Fee Related
-
2005
- 2005-03-24 US US11/088,511 patent/US20050186198A1/en not_active Abandoned
-
2006
- 2006-09-29 US US11/537,482 patent/US20070037813A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NO20013462D0 (no) | 2001-07-12 |
| US6472393B1 (en) | 2002-10-29 |
| EP1144373B1 (de) | 2005-10-19 |
| CN100488947C (zh) | 2009-05-20 |
| JP2002534449A (ja) | 2002-10-15 |
| US20070037813A1 (en) | 2007-02-15 |
| HUP0105077A2 (hu) | 2002-05-29 |
| DE60023266D1 (de) | 2005-11-24 |
| IL144032A (en) | 2006-06-11 |
| CN1342139A (zh) | 2002-03-27 |
| HUP0105077A3 (en) | 2005-04-28 |
| ES2251363T3 (es) | 2006-05-01 |
| AU3345100A (en) | 2000-08-01 |
| NZ512736A (en) | 2003-11-28 |
| PL350042A1 (en) | 2002-10-21 |
| WO2000041531A3 (en) | 2001-08-16 |
| CA2356934A1 (en) | 2000-07-20 |
| BR0008755A (pt) | 2007-05-29 |
| US20050186198A1 (en) | 2005-08-25 |
| KR20010101852A (ko) | 2001-11-15 |
| US20030212071A1 (en) | 2003-11-13 |
| EP1144373A3 (de) | 2002-01-02 |
| EP1144373A2 (de) | 2001-10-17 |
| WO2000041531A2 (en) | 2000-07-20 |
| US6919369B2 (en) | 2005-07-19 |
| MXPA01007038A (es) | 2002-07-30 |
| NO20013462L (no) | 2001-09-12 |
| CZ20012508A3 (cs) | 2002-02-13 |
| KR100838418B1 (ko) | 2008-06-13 |
| DE60023266T2 (de) | 2006-07-13 |
| IL144032A0 (en) | 2002-04-21 |
| AU771776B2 (en) | 2004-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60023266D1 (de) | Serinprotease-inhibitoren | |
| MXPA03009130A (es) | Compuestos de biarilo que funcionan como inhibidores de proteasa serina. | |
| ATE438615T1 (de) | Biarylverbindungen als serinproteaseinhibitoren | |
| UA74372C2 (uk) | Інгібітори серинових протеаз, фармацевтична композиція на їх основі | |
| WO2002000651A3 (en) | Factor xa inhibitors | |
| DE60122750D1 (de) | Amidine-inhibitoren der serine-proteasen | |
| IL137655A0 (en) | Quinoxalinones as serine protease inhibitors such as factor xa and thrombin | |
| NO20020217D0 (no) | Nitrogenholdige heterobicykler som faktor Xa-inhibitorer | |
| BR0011130A (pt) | Inibidores de metaloproteases | |
| NO20015462D0 (no) | Anvendelse av fthalazinderivater | |
| TR199801569T2 (xx) | Serin proteaz inhibit�rleri. | |
| PL319782A1 (en) | Inhibitors of serinic proteases and anticoagulative protecins extracted from nematodes | |
| WO2004113278A3 (en) | Acylsulfamide inhibitors of factor viia | |
| DE60113412D1 (de) | Inhibitoren von serin proteasen | |
| NO20004698L (no) | Quinoksalinoner som serin protease inhibitorer sÕ som faktor XA og trombin | |
| ATE275544T1 (de) | Serinprotease-inhibitoren | |
| TR199801704T2 (xx) | Serin proteaz inhibit�rleri. | |
| NO20002848L (no) | Nye forbindelser | |
| DE60113252D1 (de) | Inhibitoren von serin proteasen | |
| WO2002002519A3 (en) | THROMBIN OR FACTOR Xa INHIBITORS | |
| AU8184301A (en) | Inhibitors for the blood-clotting factor xa | |
| NO20010569L (no) | Proteaseinhibitorer for anvendelse ved behandling av psoriasis | |
| IS7162A (is) | Nýjar möndlusýruafleiður og notkun þeirra sem þrombínhemla | |
| WO2003051831A3 (en) | Protease inhibitors of the coagulation cascade isolated from dysidea sponges |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |